Sinotherapeutics Inc. (SHA:688247)

Sinotherapeutics Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 11, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,481	4,517	4,978	7,593	-	-
Market Cap Growth	-8.69%	-9.25%	-34.45%	-	-	-
Enterprise Value	3,716	3,769	4,194	6,771	-	-
Last Close Price	9.98	10.00	10.83	16.44	-	-
PE Ratio	47.11	35.37	81.50	81.71	-	-
PS Ratio	9.33	8.83	16.60	30.67	-	-
PB Ratio	3.43	3.55	4.11	6.45	-	-
P/TBV Ratio	3.52	3.66	4.28	6.74	-	-
P/FCF Ratio	131.09	127.97	-	-	-	-
P/OCF Ratio	37.39	34.69	384.14	103.76	-	-
EV/Sales Ratio	7.73	7.37	13.99	27.35	-	-
EV/EBITDA Ratio	36.59	27.36	62.24	80.84	-	-
EV/EBIT Ratio	42.82	31.55	94.67	116.33	-	-
EV/FCF Ratio	108.70	106.79	-	-	-	-
Debt / Equity Ratio	0	0	0	0.00	0.01	-
Debt / EBITDA Ratio	0.00	0.00	0.00	0.02	0.04	-
Debt / FCF Ratio	0.00	0	-	-	0.03	-
Asset Turnover	0.33	0.36	0.22	0.23	0.39	0.51
Inventory Turnover	2.69	2.63	2.34	1.96	1.71	2.29
Quick Ratio	10.84	8.19	9.13	9.76	6.21	3.37
Current Ratio	12.21	9.46	10.49	10.59	6.91	3.83
Return on Equity (ROE)	7.75%	10.29%	5.12%	9.87%	21.29%	24.97%
Return on Assets (ROA)	3.76%	5.31%	2.06%	3.31%	7.41%	12.26%
Return on Capital (ROIC)	4.26%	6.01%	2.32%	3.85%	9.35%	15.53%
Return on Capital Employed (ROCE)	6.30%	8.80%	3.50%	4.70%	12.30%	20.60%
Earnings Yield	2.20%	2.83%	1.23%	1.22%	-	-
FCF Yield	0.76%	0.78%	-0.52%	-1.36%	-	-
Dividend Yield	0.50%	0.62%	0.38%	0.38%	-	-
Payout Ratio	28.24%	21.83%	46.02%	-	-	-
Buyback Yield / Dilution	0.93%	2.92%	-11.22%	-3.32%	-0.21%	-
Total Shareholder Return	1.43%	3.54%	-10.84%	-2.94%	-0.21%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.